Increasing and dampening the nocebo response following medicine-taking: A randomised controlled trial.

Media Medicine information Nocebo effect Nocebo-explanation Side effects

Journal

Journal of psychosomatic research
ISSN: 1879-1360
Titre abrégé: J Psychosom Res
Pays: England
ID NLM: 0376333

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 03 02 2021
revised: 24 08 2021
accepted: 23 09 2021
pubmed: 5 10 2021
medline: 25 11 2021
entrez: 4 10 2021
Statut: ppublish

Résumé

The nocebo effect is the adverse effects of treatment that cannot be attributed to a medicine. We investigated if we could increase or decrease nocebo responding following medicine taking. A nocebo explanation to reduce side effects was compared with a negative medication news item designed to increase side effects and a control condition. 108 healthy participants enrolled in a between-subjects study purportedly testing the effect of lamotrigine (actually placebo) on mood and cognition. Participants were randomised to watch either a video explaining the nocebo effect; a negative media item on lamotrigine, or control video prior to receiving the tablet. Side effects were assessed at 45-min and 48-h. The negative media group reported significantly more side effects (M = 0.78, SD = 1.53) than the control group (M = 0.46, SD = 1.80, p = .035) at the end of session and a greater proportion of the negative media group (33%) reported at least one side effect compared to the nocebo explanation (11%) and control group (11%, p = .020). The nocebo explanation group reported significantly fewer side effects (M = 0.38, SD = 1.16) than the control group (M = 1.37, SD = 2.98, p = .038) at the 48-h follow-up. Explaining the nocebo effect may be a beneficial addition to standard medicine information for reducing side effect reporting. Negative media coverage about a drug is likely to generate increased side effects. Future research should examine the benefit of nocebo explanation in patients starting new medicines.

Identifiants

pubmed: 34607238
pii: S0022-3999(21)00275-0
doi: 10.1016/j.jpsychores.2021.110630
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

110630

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Kate MacKrill (K)

Department of Psychological Medicine, University of Auckland, Auckland, New Zealand.

Zara Morrison (Z)

Department of Psychological Medicine, University of Auckland, Auckland, New Zealand.

Keith J Petrie (KJ)

Department of Psychological Medicine, University of Auckland, Auckland, New Zealand. Electronic address: kj.petrie@auckland.ac.nz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH